BSE Live
Oct 29, 16:01Prev. Close
366.55
Open Price
359.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Trident Texofab (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 4.00 | 4.00 | 4.00 | 0.33 | 0.33 | |
| Total Share Capital | 4.20 | 4.20 | 4.00 | 0.33 | 0.33 | |
| Reserves and Surplus | 7.43 | 6.80 | 4.27 | 3.46 | 3.13 | |
| Total Reserves and Surplus | 7.43 | 6.80 | 4.27 | 3.46 | 3.13 | |
| Total Shareholders Funds | 11.62 | 11.00 | 8.26 | 3.79 | 3.46 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 10.55 | 9.25 | 4.17 | 5.18 | 0.51 | |
| Deferred Tax Liabilities [Net] | 0.31 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Other Long Term Liabilities | 3.93 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 14.80 | 9.26 | 4.19 | 5.20 | 0.52 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 9.81 | 3.60 | 0.00 | 0.00 | 2.47 | |
| Trade Payables | 16.03 | 19.39 | 30.31 | 14.84 | 30.80 | |
| Other Current Liabilities | 3.21 | 2.57 | 1.28 | 0.43 | 0.73 | |
| Short Term Provisions | 0.20 | 1.23 | 0.89 | 0.23 | 0.00 | |
| Total Current Liabilities | 29.25 | 26.79 | 32.48 | 15.49 | 34.00 | |
| Total Capital And Liabilities | 55.68 | 47.04 | 44.94 | 24.48 | 37.99 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 12.48 | 2.36 | 1.56 | 1.25 | 1.33 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.30 | 6.39 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 12.78 | 8.75 | 1.56 | 1.25 | 1.33 | |
| Non-Current Investments | 1.12 | 1.42 | 2.65 | 0.82 | 0.33 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.01 | 0.37 | 0.49 | 0.20 | 0.13 | |
| Other Non-Current Assets | 1.83 | 0.42 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 15.74 | 10.96 | 4.70 | 2.27 | 1.78 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 10.11 | 3.93 | 5.07 | 2.31 | 9.38 | |
| Trade Receivables | 26.43 | 29.40 | 32.13 | 15.40 | 26.03 | |
| Cash And Cash Equivalents | 0.08 | 0.39 | 0.23 | 1.86 | 0.16 | |
| Short Term Loans And Advances | 1.80 | 1.78 | 2.33 | 2.58 | 0.63 | |
| OtherCurrentAssets | 1.51 | 0.59 | 0.47 | 0.07 | 0.00 | |
| Total Current Assets | 39.94 | 36.08 | 40.23 | 22.21 | 36.20 | |
| Total Assets | 55.68 | 47.04 | 44.94 | 24.48 | 37.99 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.44 | 0.39 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 2.32 | 2.32 | 2.32 | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 1.12 | 0.90 | 0.49 | 0.35 | 0.25 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017